Webinars, Pharmaceutical

From pMDI Device to Therapeutic Effect

Pressurized metered dose inhalers, a critical solution for routine respiratory drug delivery, are currently the subject of considerable development activity. As manufacturers tackle the transition to low GWP (Global Warming Potential) propellants alongside evolving requirements for connected devices and lower cost medicines the need for more effective tools for pMDI formulation and reformulation intensifies.

This webinar showcases SmartTrack™, a novel integrated solution from Aptar Pharma that accelerates pMDI development. SmartTrack™ incorporates in vitro and in silico techniques that characterize every important process from pMDI actuation to drug delivery to the patient, and includes an alternative approach to comparative clinical endpoint for demonstrating bioequivalence. It can reduce time-to-market and program costs by accelerating new product development and regulatory decision-making.

Learn more from our experts about the challenges of reformulation with low GWP propellants, the value of using an integrated suite of tools to address them, and what SmartTrack™ can deliver. Case study data from the reformulation of a well-known API with a low GWP propellant are presented.

Watch the webinar From pMDI Device to Therapeutic Effect
Speaker(s): Chris Baron Will Ganley
16 Nov 2022

Learn more about Aptar Pharma Expertise
in Pulmonary Drug Delivery

Find Out More About pulmonary drug delivery expertise

This Might Also Be of Interest

24 Apr 2024

Advancing OINDP Clinical Trials with Speed and Efficiency: Strategies for Success

Publications, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions

Read More
24 Apr 2024

Exploring Nasal Casts in Nasal Drug Development

Publications, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions

Read More
22 Apr 2024

Navigating the Shift to more sustainable Low GWP propellants in pMDIs

Publications, Pharmaceutical, Product Solutions, Sustainability, Brand Differentiation, Market Insights

Read More
26 Mar 2024

Optimizing Preclinical Studies for Intranasal and Pulmonary Programs

Webinars, Pharmaceutical, Innovation & Insights, Device Innovations, Market Insights, Product Solutions

Read More
1 2 3 19

Request Access

Close

Requesting access to From pMDI Device to Therapeutic Effect.

  • This field is for validation purposes and should be left unchanged.
Back To Top